Adam Havey is VP at Emergent BioSolutions Inc. (EBS). They have made 21 open-market trades across 1 company since 2011, most recently 2023-06-09.
CIK 0001514588
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3K since 2015, against 20 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EBS | 125,167 | $798K |
Shares reported on the most recent Form 4, priced at the 2023-06-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EBS | SELL | 2021-03-01 | 2021-03-03 | $99.30 | $7.4M | -1.6% | -15.8% | -33.9% |
| EBS | SELL | 2020-04-17 | 2020-04-21 | $66.82 | $2.5M | +15.9% | +21.5% | +50.3% |
| EBS | SELL | 2020-04-06 | 2020-04-08 | $60.00 | $478K | +5.5% | +27.2% | +41.0% |
| EBS | SELL | 2019-03-11 | 2019-03-13 | $56.93 | $277K | -4.9% | +3.1% | -14.3% |
| EBS | SELL | 2019-02-28 | 2019-03-04 | $58.11 | $354K | -12.3% | -10.9% | -25.1% |
| EBS | SELL | 2018-11-01 | 2018-11-05 | $64.11 | $653K | +0.6% | +1.8% | -6.7% |
| EBS | SELL · 10b5-1 | 2018-10-17 | 2018-10-19 | $61.50 | $19K | +0.0% | +13.9% | +2.3% |
| EBS | SELL · 10b5-1 | 2018-10-17 | 2018-10-24 | $63.50 | $20K | +14.2% | +21.1% | +3.6% |
| EBS | SELL | 2018-10-16 | 2018-10-17 | $61.50 | $379K | -6.0% | +13.3% | +2.9% |
| EBS | SELL | 2018-10-15 | 2018-10-17 | $60.72 | $2.1M | -6.0% | +13.3% | +2.9% |
| EBS | SELL | 2018-10-15 | 2018-10-17 | $60.09 | $741K | -6.0% | +13.3% | +2.9% |
| EBS | SELL | 2018-03-12 | 2018-03-13 | $52.82 | $617K | -0.5% | +1.8% | -0.8% |
| EBS | SELL | 2018-03-01 | 2018-03-01 | $49.50 | $94K | +8.5% | +4.1% | +8.3% |
| EBS | SELL | 2017-09-27 | 2017-09-29 | $39.50 | $623K | +0.0% | +1.3% | +17.9% |
| EBS | SELL | 2017-09-08 | 2017-09-12 | $37.06 | $584K | -0.1% | +3.9% | +14.9% |
| EBS | SELL | 2017-04-03 | 2017-04-04 | $28.62 | $654K | -0.4% | +7.9% | +20.1% |
| EBS | SELL | 2017-01-17 | 2017-01-19 | $29.75 | $502K | +3.2% | +2.3% | -2.0% |
| EBS | SELL | 2016-03-14 | 2016-03-16 | $33.96 | $296K | +8.3% | +20.7% | +27.4% |
| EBS | SELL | 2016-03-11 | 2016-03-15 | $33.84 | $752K | +1.5% | +17.0% | +24.8% |
| EBS | SELL · 10b5-1 | 2015-06-15 | 2015-06-17 | $31.55 | $1.1M | -12.7% | -2.9% | -2.9% |
| EBS | BUY | 2015-06-01 | 2015-06-02 | $27.08 | $3K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2014-03-12 | 2014-03-13 | $27.50 | $318K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2014-03-11 | 2014-03-12 | $26.96 | $476K | -12.7% | -2.9% | -2.9% |
| EBS | SELL | 2011-03-11 | 2011-03-15 | $19.20 | $128K | -12.7% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.